European experts unite to personalize cancer care for kids with relapsed leukemia

NCT ID NCT05270096

First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 16 times

Summary

This study brings together a team of specialists across Europe to review each child's unique cancer genetics and recommend the most promising treatment from available options. It includes 600 children and young adults up to age 25 with relapsed or hard-to-treat blood cancers. The goal is to see how often doctors follow the expert advice and to track patient outcomes, helping to refine future treatment strategies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Newcastle Hospital

    RECRUITING

    Newcastle, United Kingdom

    Contact Email: •••••@•••••

  • Princess Máxima Center for Pediatric Oncology

    RECRUITING

    Utrecht, Utrecht, 3584CS, Netherlands

    Contact Email: •••••@•••••

  • Queen Silvia

    RECRUITING

    Gothenburg, Sweden

    Contact Email: •••••@•••••

  • Righospitalet

    RECRUITING

    Copenhagen, Denmark

    Contact Email: •••••@•••••

  • Semmelweis

    RECRUITING

    Budapest, Hungary

    Contact Email: •••••@•••••

  • UH Gent

    RECRUITING

    Ghent, Belgium

    Contact Email: •••••@•••••

  • Vall d'Hebron

    RECRUITING

    Barcelona, Spain

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.